Title : Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes.

Pub. Date : 2021 Sep 29

PMID : 34588467






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We compared the risk of prematurity, low birth weight (LBW), major congenital malformations (MCM), and spontaneous abortions (SA) associated with gestational use of DHE or triptans. Dihydroergotamine acyl-CoA synthetase medium chain family member 3 Homo sapiens
2 Adjusting for potential confounders, DHE and triptans were associated with increased risks of prematurity, LBW, MCM, and SA but not all estimates were statistically significant. Dihydroergotamine acyl-CoA synthetase medium chain family member 3 Homo sapiens